To conclude, this study firstly categorized patients into three groups according to malignancies and tumor biomarkers, and thereafter compared the intergroup phenotypes of MADM in one single center located in eastern China and suggested that anti-TIF1γ and anti-Mi2 autoantibodies may be useful predictors. Here, TRIM33 is linked to neoplasm.